For: | Maurya DK, Bandekar M, Sandur SK. Soluble factors secreted by human Wharton’s jelly mesenchymal stromal/stem cells exhibit therapeutic radioprotection: A mechanistic study with integrating network biology. World J Stem Cells 2022; 14(5): 347-361 [PMID: 35722198 DOI: 10.4252/wjsc.v14.i5.347] |
---|---|
URL: | https://www.wjgnet.com/1948-0210/full/v14/i5/347.htm |
Number | Citing Articles |
1 |
Prashasti Sharma, Dharmendra Kumar Maurya. Wharton’s jelly mesenchymal stem cells: Future regenerative medicine for clinical applications in mitigation of radiation injury. World Journal of Stem Cells 2024; 16(7): 742-759 doi: 10.4252/wjsc.v16.i7.742
|
2 |
Kate Hurley, Rachel Clow, Ashok Jadhav, Edouard I. Azzam, Yi Wang. Mitigation of acute radiation syndrome (ARS) with human umbilical cord blood. International Journal of Radiation Biology 2024; 100(3): 317 doi: 10.1080/09553002.2023.2277372
|
3 |
Jiah Shin Chin, Mandy Li Ling Tan, Priscilla Lay Keng Lim, Bhavya Sharma, Aimin Yeo, Yi Bing Aw, Yi Zhen Ng, Carine Bonnard, David L. Becker, Pamela Mok. Secretome from prolonged high‐density human Wharton's jelly stem cell culture accelerates wound healing in both in vitro and in vivo models. International Wound Journal 2025; 22(5) doi: 10.1111/iwj.70033
|
4 |
Dharmendra Kumar Maurya, Santosh Kumar Sandur. Future Perspectives of Wharton’s Jelly Mesenchymal Stem Cells and their
Soluble Factors in Radioprotection. Current Stem Cell Research & Therapy 2024; 19(6): 781 doi: 10.2174/1574888X18666230119103905
|